(ORKA) Oruka Therapeutics - Performance -39.6% in 12m
ORKA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-70.97%
#107 in Peer-Group
Rel. Strength
13.69%
#6566 in Stock-Universe
Total Return 12m
-39.56%
#107 in Peer-Group
Total Return 5y
-72.71%
#88 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 30.49 USD |
| 52 Week Low | 6.78 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 77.51 |
| Buy/Sell Signal +-5 | -0.66 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ORKA (-39.6%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ORKA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ORKA
| Total Return (including Dividends) | ORKA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 32.77% | 7.76% | 1.11% |
| 3 Months | 5.63% | -5.31% | 5.58% |
| 12 Months | -39.56% | -7.58% | 10.51% |
| 5 Years | -72.71% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | ORKA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 95.2% | 84.2% | 69.9% |
| 3 Months | 31.7% | -2.8% | 69.3% |
| 12 Months | -75.1% | -77.8% | 43.2% |
| 5 Years | -54.2% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #36 | 23.21% | 31.32% |
| 3 Month | #79 | 11.55% | 0.05% |
| 12 Month | #109 | -34.61% | -45.31% |
| 5 Years | #88 | -66.49% | -86.95% |
FAQs
Does Oruka Therapeutics (ORKA) outperform the market?
No,
over the last 12 months ORKA made -39.56%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months ORKA made 5.63%, while XBI made -5.31%.
Performance Comparison ORKA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ORKA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.6% | 31.7% | -43.3% | -50% |
| US NASDAQ 100 | QQQ | 0.9% | 31.3% | -42.6% | -49% |
| German DAX 40 | DAX | 2.8% | 33.5% | -59.7% | -69% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.9% | 33.7% | -45.2% | -51% |
| Hongkong Hang Seng | HSI | 0.1% | 27.7% | -62.4% | -67% |
| India NIFTY 50 | INDA | 2.3% | 34.1% | -42.3% | -38% |
| Brasil Bovespa | EWZ | -1.7% | 32.3% | -63.5% | -49% |
ORKA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1% | 31.3% | -46.1% | -62% |
| Consumer Discretionary | XLY | 1.2% | 34.6% | -33.5% | -57% |
| Consumer Staples | XLP | 0.9% | 33% | -44.8% | -46% |
| Energy | XLE | -5.3% | 29.9% | -46.9% | -43% |
| Financial | XLF | 2.2% | 35.3% | -46.2% | -63% |
| Health Care | XLV | -1.3% | 28.4% | -42.9% | -34% |
| Industrial | XLI | 1.6% | 32.4% | -48.9% | -58% |
| Materials | XLB | 1.3% | 31.4% | -44.1% | -39% |
| Real Estate | XLRE | 0.1% | 31.8% | -44.3% | -53% |
| Technology | XLK | 0.3% | 30.8% | -43.7% | -44% |
| Utilities | XLU | -0.8% | 32.2% | -51.7% | -61% |
| Aerospace & Defense | XAR | 1.6% | 27% | -60.3% | -82% |
| Biotech | XBI | 1% | 25% | -32.6% | -32% |
| Homebuilder | XHB | 2.2% | 37.8% | -27.9% | -30% |
| Retail | XRT | 4.5% | 32.9% | -35.4% | -40% |
ORKA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -11.2% | 14.1% | -53.2% | -43% |
| Natural Gas | UNG | 1.4% | 35.4% | -61.6% | -25% |
| Gold | GLD | -3% | 26.6% | -73.5% | -87% |
| Silver | SLV | 1.4% | 21.4% | -62.9% | -62% |
| Copper | CPER | 3.1% | 31.1% | -58.2% | -48% |
ORKA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0.9% | 32.1% | -41.9% | -36% |
| iShares High Yield Corp. Bond | HYG | 0.1% | 32.3% | -47% | -49% |